论文部分内容阅读
目的:观察血凝酶联合ANH在脊柱肿瘤手术中的临床疗效。方法:对照组(CG,n=20)采用ANH止血,观察组(TG,n=20)在对照组治疗基础上给予血凝酶治疗,对比两组的血液指标变化。结果:与治疗前比较,治疗组PLT,Hb和Hct水平、APTT和PT水平均无显著变化(P>0.05)。而对照组PLT,Hb和Hct水平与治疗前比较均下降,APTT和PT水平显著延长(P<0.05),而且与治疗组比较差异均有统计学意义(P<0.05)。结论:血凝酶联合ANH用于脊柱肿瘤手术中的止血高效、速效、安全、使用方便,值得临床推广。
Objective: To observe the clinical efficacy of hemagglutinin combined with ANH in spinal surgery. Methods: The control group (CG, n = 20) was given ANH hemostatic. The observation group (TG, n = 20) was given hemagglutinin treatment on the basis of the control group. Results: Compared with those before treatment, the levels of PLT, Hb and Hct, APTT and PT in treatment group had no significant changes (P> 0.05). However, the levels of PLT, Hb and Hct in control group decreased compared with those before treatment, and the levels of APTT and PT were significantly prolonged (P <0.05), and the differences were statistically significant (P <0.05). Conclusion: Hemagglutinin combined with ANH for hemostasis in spinal tumor surgery is effective, quick, safe and easy to use, which is worthy of clinical promotion.